Abstract
Improvements in Quality of Life of Patients with Multiple Sclerosis receiving Alemtuzumab in Clinical Practice: LEMVIDA study (P7-3.018)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have